Merck says experimental coronavirus pill cuts deaths and hospitalisations by half

Drug maker Merck said on Friday that its experimental Covid-19 pill reduced hospitalisations and deaths by half in people recently infected with the coronavirus, potentially a leap forward in the global fight against the pandemic.The company said it will soon ask health officials in the US and around the world to authorise the pill’s use. A decision from the US Food and Drug Administration could come within weeks after that, and the drug, if okayed, could be distributed quickly soon afterward…

Read the original article at South China Morning Post